Dec 21 (Reuters) - Novavax (NVAX.O) said on Tuesday the World Health Organization's (WHO) panel of experts had recommended a third dose of its vaccine, NVX-CoV2373, for immunocompromised persons.
The WHO's Strategic Advisory Group of Experts on Immunization, known as SAGE, issued a series of...
5th covid 19 vaccine bloc
biggest vaccine maker
country: united states
emergency use listing
first booster doses
late stage trial
middle income countries
novavaxcovidvaccinepeople
reuters novavax nvax o
strategic advisory group
